CClinicalTrials.gg
CompletedNCT03747692Updated Nov 20, 2018

Intracervical Anasthesia in Outpatient Hystroscopy, Can Procedure be Completed Diagnostic and Therapeutic With no Need to General Anaesthesia

An interventional study of study group and control group in Infertility, Female, sponsored by Cairo University. Completed at 1 site in Egypt. Open to female participants aged Up to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-11-20.

Sponsored by Cairo University · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
Up to 40 Years
Sex
Female
01

Study summary

Single blind randomized controlled study in which 80 patients coming for hystroscopy due to multiple indication as infertility, AUB and missed IUD were assigned for our study. Both Sample size and randomization were done by a computer program. Patients were classified into 2 groups, group 1 study group was subjected to intracervical injection of 5 mi of mepivacaine hydrochloride at position 3 and 9 of the vaginal portion of the cervix, and at least 5 minutes post injection before procedure done. The control group received NSAI injection 15 minutes before procedure and 5 ml of saline was injected in each side of cervix at 3 9 positions. Hystroscopy was done if an abnormality is detected an intervention was done. A descriptive scale of pain was done into mild, moderate or severe (that lead to interruption of the procedures).

Read the detailed description

Procedures:

All patients were subjected to:

  1. History taking
  2. Verbal consent to participate in our study
  3. Patient put in lithotomy position
  4. Casco speculum was applied exposing the cervix
  5. Betadine sterilization of the cervix then properly washed with saline as heavy metals of disinfectant may cause irritation with injection
  6. Multiple toothed volselum was used just to fix cervix
  7. 3 cartridges of mepivacaine hydrochloride was filled in 10 mi syringe
  8. Do aspiration to exclude and avoid intravascular injection then infilterate slowly intracervical at both 3 and 9 positions
  9. Instruments are removed and at least 5 minutes later procedure started.
  10. Hystroscopy (rigid , 2.9 mm sheath) was introduced gently throw vaginoscopy exploring vagina , cervix and uterine cavity
  11. Patient was monitored for pain all through the procedure by descriptive scale, mild, moderate and severe. ( moderate who needed to take rest then continue , severe that necessitated interruption of the procedure
  12. All patients were monitored for signs of vaso vagal attack as sings (low blood pressure and bradycardia) before and if needed during. Occurrence of symptoms as pallor , sweet and fainting
  13. All patients were monitored post procedure for persistence of colicky pain
02

Conditions studied

  • Infertility, Female

Keywords

  • intracervical anasthesia , outpatient hystroscopy ,
03

In context

Infertility

2,506 studies on the registry are indexed under Infertility; 407 are open to participants now.

This study's enrollment of 80 is below the median of 120 across 1,698 interventional studies indexed under Infertility.

Browse Infertility studies →

Lead sponsor

Cairo University is the lead sponsor of 4,780 studies on the registry; 1,427 are open to participants now.

Of its 36 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 40 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  1. must be under 40 years
  2. must be no history of renal or hepatic disease
  3. must be no known hypersensitivity to local anaesthetic agents
  4. must be no significant vaginal or cervical infection.

Exclusion criteria

Exclusion Criteria:

  • All patients with history of sever vasovagal attack during any gynecological procedures.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
80 participants (actual)

Study arms

  • Experimental
    study group

    patient put in dorsal postion , insertion of a speculum , sterilization of the cervix then intracervical injection of 5 ml mepicaine hydrochloride a local anasthetic as Carbocaine3%54 mg at site 3 and 9 using a 10 cm syringe

    Procedure: study group

  • Placebo comparator
    control group

    patient receives one tablet of NSAIDs (diclofenac sodium 50 mg )15 minutes before procedure then 5 ml of normal saline will be injected intracervical using 10 cm syringe then wait for 5 minutes before the procedure

    Procedure: control group

Interventions

  • Procedurestudy group

    local anesthesia by mepicaine hydrochloride by intracervical local injection using 10 mm syringe.

  • Procedurecontrol group

    each patient receives one tablet of NSAIDs (diclofenac sodium 50 mg) and 5ml of a placebo in form of normal saline are injected intracervical 5 minutes before the procedure using 10 mm syringe.

06

What researchers measure

Primary outcomes

  1. tolerated hystroscopy

    complete hystroscopy procedure with tolerable degree of pain.

    Time frame: 30 minutes

Secondary outcomes

  1. occurrence of complication

    symptoms of vasovagal as vomiting , sweeting and bradycardia

    Time frame: 30 minutes

07

Study locations

1 site
  • Outpatient Hystroscopy of Kasr El Ainy
    Giza, 12521, Egypt
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 20, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03747692
Lead sponsor
Cairo University
Responsible party
Olfat Nooh Riad Ali (professor in cairo univerity, Cairo University) — Principal investigator
First posted
Nov 20, 2018
Start date
Aug 15, 2018
Primary completion
Oct 20, 2018
Completion
Oct 30, 2018
Last update
Nov 20, 2018

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion